Search Results
PCSK9 antagonists: A real breakthrough for management of familial hypercholesterolaemia? ESC2016
Is lipoprotein(a) a cause of clinical familial hypercholesterolaemia?
Scientific Insights Into LDL-C, PCSK9, and CV RISKS
ESC 2015: PCSK9 a ‘game changer’ in the treatment of familial hypercholesterolaemia
The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia
Are the two PCSK9 inhibitors really game changers? What is your experience with them?
Were PCSK9 Inhibitors Overhyped?
PCSK9 Inhibitors Show Benefits with Challenges to Overcome
ACC.14 | First Phase 3 Data Being Reported for a PCSK9 Inhibitors
This LDL level is Dangerous (Avery’s Homozygous FH)
What is Familial Hypercholesterolaemia?
Robert Eckel, MD, Discusses Lipid Management in the PCSK9 Era